青年乳腺癌中XIAP、Smac、Caspase-3的表达及其与HER2的相关性研究
被引量:2
摘要
乳腺癌是女性最常见的恶性肿瘤之一。一般认为35岁以下青年乳腺癌患者在生物学行为及预后方面不同于其他年龄段患者,因此将之定义为青年乳腺癌。作者对本院近年来收治的35岁以下乳腺癌病例进行回顾性分析,
出处
《河北医科大学学报》
CAS
2012年第10期1214-1216,共3页
Journal of Hebei Medical University
参考文献5
-
1季永领,杜向慧.青年乳腺癌的研究进展[J].中国癌症防治杂志,2010,2(3):244-246. 被引量:4
-
2COLONNA M, DELAFOSSE P, UHRY Z, et al. Is breast cancer incidence increasing among young women? An analysis of the trend in France for the period 1983 - 2002 [ J]. Breast ,2008,17 ( 3 ) : 289 - 292.
-
3WANG ZH, CHEN H, GUO HC, et al. Enhanced antitumor efficacy by the combination of emodin and gemcitabine against human pancreatic cancer cells via downregulation of the expression of XIAP in vitro and in vivo[ J ]. lnt J 0ncol,2011,39 (5) :1123 - 1131.
-
4YANG D,ZHAO Y,LI AY ,et al. Smac -mimetic compound SM - 164 induces radiosensitization in breast cancer cells through activation of caspases and induction of apoptosis [ J ]. Breast Cancer Res Treat,2012,133 ( 1 ) : 189 - 199.
-
5GONZ.~LEZ - L6PEZ M, WELSH K, FINLAY D, et al. Design, synthesis and evaluation of monovalent Smac mimetics that bind to the BIR2 domain of the anti - apoptotic protein XIAP [ J ]. Bioorg Med Chem Lett,2011,21 (14) :4332 -4336.
二级参考文献34
-
1王中华,徐兵河.129例30岁以下女性乳腺癌的临床特点及预后分析[J].中华肿瘤杂志,2005,27(2):111-113. 被引量:40
-
2张晨芳,康慧鑫,张宏,刘颖.青年乳腺癌97例临床特点及预后分析[J].实用医学杂志,2006,22(12):1426-1427. 被引量:8
-
3Houssami N,Irwig L,Simpson JM,et al.Sydney breast imaging accuracy study:comparative sensitivity and specificity of mammography and sonography in young women with symptoms[J].Am J Roentgenol,2003,180:935-940.
-
4Braun M,P(O)lcher M,Schrading S.Influence of preoperative MRI on the surgical manasement of patiento with operable bream cancer[J].Breast Cancer Res Treat,2008 Sep,111(1):179-187.
-
5Vallow L,Packianathan S,Feigel D.Analysis of magnetic resonance imaging(MRI)in the detection of mammographically occult breast carcinoma[J].Journal of Clinical Oncology,2007,25:603.
-
6Voogd AC,Nielsen M,Peterse JL,et al.Differences in risk factors for local and distant recurrence after breast conserving therapy or mastectomy for Stage Ⅰ and Stage Ⅱ breast cancer:pooled Results of two large European randomized trials[J].J Clin Oncol,2001,19:1688-1697.
-
7Zhou P,Gautam S,Recht A.Factors affecting outcome for young women with early stage breast cancer treated with breastconserving therapy[J].Breast Cancer Res Treat,2007,101:51-57.
-
8Harry B,Jean-Claude H,Philip M,et al.Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer:10-year Results of the randomized boost versus no boost EORTC 22881-10882 trial[J].J Clin Oncol,2007,25:3259-3264.
-
9van-der LM,Evers L,van-der SMJC,et al.The esfety of breast-conserving therapy in patients with breast cancer aged ≤40 years[J].Cancer,2007,109:1957-1964.
-
10Axelrod D,Smith J,Kornreich D.Breast cancer in young women[J].J Am Coll Surg,2008,206:1193-1203.
共引文献3
-
1徐立坤,朱丽萍,李涌涛.术后化疗对青年乳腺癌患者卵巢功能的影响[J].新疆医科大学学报,2012,35(3):346-348. 被引量:1
-
2郭阳阳,谷元廷,王芳,邱新光.妊娠期乳腺癌的研究与诊治进展[J].国际外科学杂志,2014,41(3):158-161. 被引量:6
-
3石朝绩.青年乳腺癌的研究进展[J].医学理论与实践,2016,29(19):3328-3330. 被引量:2
同被引文献18
-
1SIEGEL R,WARD E, BRAWLEY O, et al.Cancer statistics,2011: the impact of eliminaling socioeconomic and racial disparities on premature cancer deaths[J].CA Cancer J Clin, 2011,61(4) :212-236.
-
2WANG S, BAI L, LU J ,et al.Targeting inhibitors of apoptosis proteins (IAPs) for new breast cancer therapeutics [J]. J Mammary Gland Biol Neoplasia,2012,17(3/4):217-228.
-
3VICKERS CJ, GONZ -ALEZ-PAEZ GE. WOLAN DW. Selective detection and inhibition of active caspase 3 in cells with optimized peptides[J].J Am Chem Soc,2013,135 (34): 12869-12876.
-
4YAO Q,CHEN J ,LV Y,et al. The significance of expression of autophagy-related gene Beclin, Bcl-2, and Bax in breast cancer tissues[J].Tumour Biol,2011,32(6):1163-1171.
-
5孟丽,黄向华,李晓冬,赵肖丽,李芳,边欣.Ki-67、bcl-2、Survivin和Cyclin D1在子宫内膜息肉及其周围内膜的表达及其意义[J].河北医科大学学报,2011,32(9):1011-1014. 被引量:2
-
6徐勤,高珊,赵瑞力,胡俊兰.Livin和Caspase-3与恶性肿瘤的研究进展[J].临床荟萃,2012,27(11):997-1001. 被引量:8
-
7梁健,赵敏,张红斌,梁香存,才虹美,郭素敏.紫杉醇脂质体联合顺铂治疗晚期非小细胞肺癌120例疗效评价[J].河北医科大学学报,2012,33(9):1051-1053. 被引量:7
-
8覃利菊.卵巢癌诊断和治疗的现状及进展[J].中外医学研究,2013,11(19):147-149. 被引量:15
-
9闫丽,宋琳.食管癌患者临床病理特征与生存素及表皮生长因子受体蛋白质表达的关系[J].临床荟萃,2013,28(9):973-975. 被引量:4
-
10农大件,李国成,周围.神经胶质瘤的治疗研究进展[J].中国医药指南,2013,11(26):58-60. 被引量:9
二级引证文献10
-
1黄平,张立民,黄冬冬,裴新伟,史春燕.缺氧诱导因子1α在促卵泡激素促进卵巢癌SKOV3细胞增殖与侵袭中的作用[J].河北医科大学学报,2016,37(4):450-453. 被引量:5
-
2常征,王惠兰,乔宗旭,李娜,马华姝.银杏黄酮、氨磷汀及亮丙瑞林对顺铂抑制卵巢恶性畸胎瘤细胞作用的影响[J].河北医科大学学报,2016,37(10):1208-1211. 被引量:3
-
3叶双梅,马湘一,王世宣.DT390与TMTP1融合蛋白靶向治疗卵巢癌的实验研究[J].中国肿瘤临床,2018,45(5):217-221. 被引量:1
-
4刘春杰,刘宇,邓学坤,王军童,张月明,张义庚.miR-32通过调控PI3K/Akt信号通路影响骨肉瘤细胞的增殖[J].河北医科大学学报,2018,39(6):662-667. 被引量:7
-
5杨建凯,齐雪姣,焦保华,赵宗茂,吕中强,李琛.GBM细胞来源外泌体促进小胶质细胞介导的炎症反应[J].河北医科大学学报,2018,39(11):1311-1315. 被引量:6
-
6李晓明,李胜棉.血清miRNAs检测在肝癌中的临床应用价值[J].河北医科大学学报,2018,39(4):492-496. 被引量:11
-
7彭昊骄,刘辉.X染色体连锁凋亡抑制蛋白及其相关因子1与妇科肿瘤化疗耐药[J].中华妇幼临床医学杂志(电子版),2019,15(3):353-356. 被引量:4
-
8田鹏飞,陈娟娟,尹俊杰,李冰,郭珊.柔红霉素对人B细胞淋巴瘤OCI-LY7细胞凋亡的诱导作用及其机制[J].吉林大学学报(医学版),2019,45(6):1340-1345. 被引量:1
-
9肖华,姚声涛.转染TRIM29-siRNA对胶质瘤U87MG细胞周期和凋亡的影响[J].吉林大学学报(医学版),2020,46(2):323-328.
-
10张靖,白惠娟.circBIRC6靶向miR-367-3p对卵巢癌细胞顺铂耐药性的影响[J].中华肿瘤杂志,2021,43(10):1062-1068. 被引量:3
-
1熊立新.VEGF和EGFR在青年乳腺癌的表达及其与淋巴结转移的关系[J].中国普通外科杂志,2012,21(5):614-616. 被引量:7
-
2章阳,易铁男,刘晓洪,肖天林.BRCA1和Ki-67在青年乳腺癌患者组织中的表达及临床意义[J].中国肿瘤临床与康复,2013,20(5):471-473. 被引量:2
-
3吴婷.青年乳腺癌患者的临床病理特征分析(附42例报告)[J].医学理论与实践,2012,25(15):1899-1900. 被引量:5
-
4邰亦成,黄贵,朱伟良,程锦玲.35岁以下青年乳腺癌患者不同分子亚型的临床病理学特征[J].包头医学院学报,2016,32(10):73-74.
-
5肖祥胜,李峻,王曦,韦尉东,唐军,刘鹏,谢小明.青年乳腺癌209例生存分析[J].中国医师进修杂志,2010,33(35):41-43. 被引量:2
-
6安松林,方志沂,于泳.青年乳腺癌的临床特点及预后[J].实用癌症杂志,2005,20(6):639-642. 被引量:14
-
7华晨,邓甬川,陈丽荣.青年乳腺癌特点及预后[J].浙江预防医学,2004,16(7):11-12. 被引量:35
-
8廖佳建,叶长生,刘民锋,甄乐峰.青年乳腺癌VEGF和EGFR的表达及其与临床病理的关系[J].重庆医学,2010,39(13):1652-1653. 被引量:3
-
9李成贻,曹明智,孔滨,刘妮.41例青年乳腺癌ER、PR、CerbB-2、PCNA表达及其临床特征[J].现代中西医结合杂志,2007,16(3):309-310. 被引量:12
-
10陈丽敏,刘健,郑弘宇,范南峰,陈强.123例青年乳腺癌临床特点及预后分析[J].中国肺癌杂志,2009,12(6):647-650. 被引量:9